SUPERNUS PHARMACEUTICALS, INC. Lessee, Operating Lease, Liability, to be Paid, Year Two in USD from Q1 2019 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
Supernus Pharmaceuticals, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Two history and growth rate from Q1 2019 to Q4 2024.
  • Supernus Pharmaceuticals, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Two for the quarter ending December 31, 2024 was $6.96M.
Lessee, Operating Lease, Liability, to be Paid, Year Two, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year Two, YoY Quarterly Growth (%)

SUPERNUS PHARMACEUTICALS, INC. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Two (USD)

Period Value YoY Chg Change % Date Report Filed
Q4 2024 $6.96M Dec 31, 2024 10-K 2025-02-25
Q4 2022 $7.65M -$88K -1.14% Dec 31, 2022 10-K 2023-03-09
Q4 2021 $7.73M +$3.26M +72.8% Dec 31, 2021 10-K 2022-04-13
Q4 2020 $4.47M +$344K +8.33% Dec 31, 2020 10-K 2021-03-08
Q1 2020 $4.76M +$1.82M +62% Mar 31, 2020 10-Q 2020-05-15
Q4 2019 $4.13M Dec 31, 2019 10-K 2020-02-28
Q3 2019 $3.09M Sep 30, 2019 10-Q 2019-11-08
Q2 2019 $3.05M Jun 30, 2019 10-Q 2019-08-09
Q1 2019 $2.94M Mar 31, 2019 10-Q 2019-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.